Our connected experts unlock, activate and optimize the value of your healthcare innovation at each pivotal moment of your product launch journey.
Watch this on-demand webinar, in which our expert panellists discuss common challenges faced during the product launch journey, from pre-launch to keeping the momentum going post-launch.
Strategic alignment across each pivotal moment is crucial to your success, and we’re by your side at every step of the journey.
Underpinned by evidence, data and technology to help navigate your most complex challenges, Inizio Launch Elevate provides breadth of expertise and connected capabilities designed to accelerate and simplify your product launch.
*Based on company revenue data 2021-2022 & external sources (Evaluate Pharma)
Unlock your product’s innovation: Our connected capabilities across market and patient insights, launch strategy and framework development help ensure strategic team alignment throughout your product launch.
Overcome evolving challenges: Equip your MSLs with scientific and medical education and training that addresses key challenges by creating engaging, informed stakeholder interactions at product launch and beyond.
Harness comprehensive and customized solutions: Achieve successful product launches through a tailor-made approach to brand development and marketing excellence; from launch strategy and customer engagement to omnichannel marketing and post-launch performance management.
Confidently navigate the complex product launch landscape: Mobilize and train your teams across scientific, medical, patient and promotional engagement to deliver the right message at the right time in the right channel to inspire lasting change.
The journey to patients is a multi-year and resource intensive effort with high commercial stakes at play. Throughout it there are an array of “get-right” pivotal moments for pharma and biopharma that acutely influence the likelihood of product success and pace in the purposeful endeavor to speedily get the right treatments to patients who need it the most. Below outlines this journey and several pivotal moments.
• Identify target disease and develop drug to modulate it
• Estimate potential benefit and identify patient population
• Drug enters pre-clinical and clinical test stages (Phase I, II, III) to assess compound safety, efficacy and mechanism of action
• Regulatory submission, review and approval
• Capture stakeholder/customer/physician insights to inform market access and commercialization strategy
• Develop pricing and reimbursement strategy
• Identify and develop product unique value proposition
• Launch planning
• Activation of drug commercialisation strategy including drug marketing and promotion
• Stakeholder engagement (Key Opinion Leaders, Healthcare Professionals, payers and patients)
• Sales force effectiveness
• Initiation of patient support programs
• Post-marketing surveillance (sales, performance, market trends, patient feedback)
• Real-World Evidence (RWE) tracking to monitor drug efficacy/safety and demonstrate cost-effectiveness to payers/healthcare decision-makers
A large global life sciences company needed support in developing a product launch operating model that would enable the delivery of several key therapies to market over the next three years. Our experts partnered with their team to help provide clarity on roles and responsibilities, ways of working, and behaviors that would make future product launches effective.
A global Life Sciences company was set to launch a new oncology drug in the US market without a formal team or strategy in place a year before the anticipated FDA approval. By engaging with our experts, we helped to establish a diverse launch team across 15+ functional areas and develop the tools and governance needed for efficient and repeated successful launches in the future.
A life sciences company specializing in molecular diagnostics faced an unparalleled challenge: facilitating the rapid development, authorization and launch of a point-of-care COVID-19 testing system. With the help of our product launch experts, the test was shipped less than 10 days after FDA authorisation to hospitals across the US.
A leading global pharmaceutical company had developed a promising treatment for Ulcerative Colitis but needed to understand the product’s potential in the US market to maximize its commercial impact. Our experts developed a contracting strategy comparing standalone versus portfolio offerings, produced detailed financial modelling, and delivered a full suite of HEOR launch materials to demonstrate cost-effectiveness for payers.
Creating long-term value for patients through end-to-end advisory services.
Creating compelling content to achieve outcomes that matter.
Global brand, experience and communications platform.
Creating personalized experiences that deliver improved treatment outcomes.
Read the latest insights and guidance from our product launch experts.
Leveraging our connected suite of capabilities, our experts will guide you through each pivotal moment in your asset’s lifecycle, creating tailored solutions that simplify the complex, unlock value, and enhance treatment outcomes.
